Trial Profile
A multi-center non-interventional study (NIS) to assess practicability, effectiveness and tolerability of once daily applied tacrolimus formulations used in kidney transplant patients. - TACRONIS
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Mar 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms TACRONIS
- Sponsors Chiesi
- 13 Aug 2017 Status changed from not yet recruiting to recruiting.
- 13 Dec 2016 New trial record